Nicolas Devaud, MD retweeted
Variability in treatment approaches, outcomes, and recurrence patterns... sciencedirect.com/science/ar… @TARPSWG @ctosociety @SMEOMX @devaud_nicolas @sarresurgeon @DrPaulAdriazola @SelnetH2020 @SoMe4sarcoma #retroperitonealsarccoma #SARCOMA
Nicolas Devaud, MD retweeted
Toronto fellows past and present representing at @ctosociety @homeofguinness
Nicolas Devaud, MD retweeted
Congrats @sarresurgeon @DorianGarciaMD @devaud_nicolas and welcome LATAMSARC collaborative! @TARPSWG @SoMe4sarcoma
Congratulations Dr. Sarre @sarresurgeon on this very important work -proud to work with you @UofTSurgOnc. Come check out her poster! @ctosociety
Nicolas Devaud, MD retweeted
@TARPSG dinner at Clontarf Castle Hotel in beautiful Dublin. @mylessmith giving the welcome to the group! Lots of fun and engagements!
Nicolas Devaud, MD retweeted
🆕Review - free to read and download
Complex Vascular Resections for Retroperitoneal Soft Tissue #Sarcoma
by Nicolas A. Devaud, Jean M. Butte et al
➡️mdpi.com/1718-7729/30/3/266
Nicolas Devaud, MD retweeted
Replying to @devaud_nicolas @Seanpcleary @ZhiVenFongMD @AmrAliRagab @HopSTranCao @cutitoutPODCAS1 @shimulshah73 @mj_pucci @AmarGupta_MD @HPB_Knife @NirajGusani @rachnatshroff
Gem Cis abraxane was based on a positive phase II study. However, recent SWOG 1815 randomized phase III presented at GI @ASCO was negative. There were subsets that benefitted, but not powered for. So for advanced BTC, Gem Cis Durva is what most consider standard (TOPAZ study).
Nicolas Devaud, MD retweeted
There is still time to register!
Join @NANETS1 for a virtual day of learning with Latin America colleagues. Lots of great content on 🔥topics!
🔗nanets.net/regionals/latin-v…
@NETsMexico @JaydiDelRivero @AleBuerba @CukierM @CorreaCoteJC @devaud_nicolas
🏷others who may be interested👇🏻
Nicolas Devaud, MD retweeted
🌹Read Dr. Carol J. Swallow, @UofTSurgery Chair's "Message of support on National Day of Remembrance and Action on Violence Against Women" surgery.utoronto.ca/MessageO…
Nicolas Devaud, MD retweeted
Up to 30% of pts with primary localized #retroperitoneal #sarcoma are not resected. Patient selection is key. #CTOS2022 #CTOSTweeTOS @ctosociety – at Vancouver, British Columbia
Nicolas Devaud, MD retweeted
CTOS 2002 TARPSWG Semiannual Meeting tarpswg.org/2022/11/19/ctos-…
Nicolas Devaud, MD retweeted
Nicolas Devaud, MD retweeted
Great @TARPSWG l semiannual meeting, live after 3 years. Lots of discussions, ideas, interactions. Bright future ahead!thanks @ctosociety for all the support! Great start of this year @ctosociety annual meeting.
Nicolas Devaud, MD retweeted
Fantastic dinner with @TARPSWG friends at #CTOS2022 @alegronchi @WinanvanHoudt @davidgyorki @chandrajitraut @kencardonaMD @SBonvalot @devaud_nicolas
Nicolas Devaud, MD retweeted
Retroperitoneal Sarcoma and resectability/
margins by @devaud_nicolas at @ctosociety -@SelnetH2020 meeting @TARPSWG #CTOSTweeTOS
Nicolas Devaud, MD retweeted
@ELSSurgery #esophagealcancer
Features Twitter authors:
@vlitle @A_Adel90 @AlicubenEvan @ShandaBlackmon @SidraBonner @devaud_nicolas @hsupokuei @AudreyJajosky @YJanjigianMD @SNKali @LewisSalins @j_lukovic @DrGMavrogenis @k_visrodia @ewakeam
Nicolas Devaud, MD retweeted
Muy agradecido de la invitación a participar en esta edición de Las Clínicas Quirúrgicas de NorteAmerica instagram.com/p/CgjfViUrXUh/…








































